2141
Evaluation of Hepatic Function Impairment on the Pharmacokinetics of LEE011
Condition(s):Normal Hepatic Function; Impaired Hepatic FunctionLast Updated:December 19, 2020Completed
Pharmacokinetic Profile: 2162 Clinical Trials, Page 215 of 217
Hide Studies Not Open or Pending
2142
Study of Recombinant Human Serum Albumin/Interferon alpha2b Fusion Protein in Hepatitis B Patient
Condition(s):Hepatitis B VirusLast Updated:April 1, 2021Completed
2143
Study to Evaluate Safety, Pharmacokinetics, and Efficacy of Rociletinib (CO-1686) in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) in Non-Small Cell Lung Cancer (NSCLC) Patients
Condition(s):Locally Advanced or Metastatic Non Small Cell Lung CancerLast Updated:August 4, 2020Terminated
2144
The Pharmacodynamic/Pharmacokinetic Interaction of Tipranavir and Ritonavir With Loperamide in Healthy Volunteers
Condition(s):HealthyLast Updated:September 29, 2014Completed
2145
A Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson’s Disease Patients
Condition(s):Parkinson’s DiseaseLast Updated:December 11, 2019Completed
2146
AVT03 With Prolia in Healthy Male Subjects
Condition(s):Healthy Male SubjectsLast Updated:January 26, 2023Recruiting
2147
A Multiple-Dose, Open-Label, Phase 1, Pharmacokinetic, Pharmacodynamic, and Safety Study of Avonex® in Chinese Healthy Volunteer Subjects
Condition(s):HealthyLast Updated:November 4, 2011Completed
2148
TL011 in Severe, Active Rheumatoid Arthritis Patients
Condition(s):Rheumatoid ArthritisLast Updated:October 4, 2021Completed
2149
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus
Condition(s):Cutaneous Lupus; Systemic Lupus ErythematosusLast Updated:December 21, 2022Completed
2150
Study Evaluating Inhaled AeroLEF Delivered in 4 Aerosol Delivery Devices in Healthy Volunteers
Condition(s):HealthyLast Updated:November 19, 2008Completed